Accoring to the UK transparency rules and Disclosure Rules chapter 5 of the Financial Conduct Authority the Danske Bank Group, also representing Danske Invest Finland and Danske Invest Luxembourg, hereby discloses total aggregated holdings of 524.323 shares corresponding to 1,06379 percent of the total issued voting Rights in Consort Medical plc.
This announcement is distributed by Nasdaq Corporate Solutions on behalf of Nasdaq Corporate Solutions clients.
The issuer of this announcement warrants that they are solely responsible for the content, accuracy and originality of the information contained therein.
Source: Danske Bank A/S via Globenewswire